Gastric sleeve bougie sizes play a key role in determining the shape, volume, and functional capacity of the stomach remnant created during sleeve gastrectomy. A bougie — a calibration tube inserted intraoperatively — guides the surgeon's stapling device to produce a consistently sized sleeve. The size chosen, measured in French (Fr) units, can influence restriction, weight loss outcomes, reflux risk, and nutritional adequacy. This article explains how bougies are used, which sizes are most commonly employed in UK practice, how size relates to clinical outcomes, and what questions patients should raise with their bariatric surgeon before surgery.

What Is a Bougie and How Is It Used in Gastric Sleeve Surgery?

A bougie is a flexible calibration tube inserted via the oesophagus during sleeve gastrectomy to guide stapling and ensure a consistently shaped stomach remnant; it is removed once stapling is complete.

Have any more questions about this? Message our pharmaceutical team to get more info →

A bougie is a long, flexible calibration tube that a surgeon inserts into the stomach via the oesophagus during a sleeve gastrectomy procedure. Its primary purpose is to act as an internal guide, allowing the surgical team to create a consistently shaped and sized gastric sleeve — the narrow, tube-like stomach remnant that remains after the majority of the stomach is removed.

During the operation, the bougie is passed carefully into the stomach under direct laparoscopic vision and positioned along the lesser curvature. The surgeon then uses a laparoscopic stapling device to resect the stomach alongside this guide, ensuring the new sleeve is formed to a predictable diameter. Without this calibration tool, achieving a uniform sleeve shape would be considerably more difficult, potentially leading to inconsistencies in sleeve width that could affect both safety and long-term outcomes.

Although rare, passage of the bougie carries a small risk of oesophageal or gastric injury; this risk is minimised by careful insertion under direct vision by an experienced operator.

The bougie does not remain in the body — it is removed once the stapling is complete. Its role is purely intraoperative. The size of the bougie used is measured in French (Fr) units, a standard measurement of catheter and tube diameter where each French unit equals approximately 0.33 mm. This means that a 36 Fr bougie has an external diameter of roughly 12 mm.

The choice of bougie size is one of several technical decisions a bariatric surgeon makes that can meaningfully influence the functional capacity of the resulting sleeve. Another important variable is the distance from the pylorus at which resection begins — commonly 2–6 cm — as this determines how much of the antrum is preserved and also affects the final sleeve volume and function.

Common Bougie Sizes Used in Sleeve Gastrectomy Procedures

Bougie sizes of 32–42 Fr are most commonly reported; 36–38 Fr is frequently cited in contemporary literature, though no single size is mandated by NICE, BOMSS, or any international consensus body.

Bougie sizes used in sleeve gastrectomy vary across surgical centres and individual surgeons, but the most commonly reported range in published studies falls between 32 Fr and 42 Fr. Within this range, certain sizes have become more prevalent based on evolving evidence and surgical preference.

• 32–34 Fr: Considered a smaller bougie, associated with a tighter, more restrictive sleeve. Some surgeons favour this range for patients where maximal restriction is a priority.

• 36–38 Fr: Commonly reported in contemporary bariatric literature and frequently cited in surgical studies as offering a balance between restriction and safety. It should be noted that neither NICE, BOMSS, nor any single international consensus body mandates a specific bougie size; this range reflects commonly reported practice rather than a formal guideline recommendation.

• 40–42 Fr: A larger bougie producing a wider sleeve. Historically used more frequently, though less common in current practice as evidence has shifted towards smaller calibrations.

There is no single universally mandated bougie size. Surgical technique, patient anatomy, staple line placement relative to the bougie, and the distance from the pylorus at which resection begins all interact to determine the final sleeve volume. Two surgeons using the same bougie size may produce sleeves with meaningfully different volumes depending on these additional variables.

Some bariatric units in the UK have moved towards greater consistency in technique as part of quality improvement initiatives, and participation in national audit through the National Bariatric Surgery Registry (NBSR) supports ongoing evaluation of technical practices — including the impact of variables such as bougie size — at a population level. Patients and clinicians seeking UK-specific outcome data may find the NBSR annual reports a useful reference.

How Bougie Size Affects Sleeve Volume and Weight Loss Outcomes

Smaller bougies create a more restrictive sleeve that may improve short-term weight loss, but evidence is inconsistent and any benefit may attenuate beyond two years; GORD risk and nutritional adequacy are also affected.

The diameter of the bougie used during sleeve gastrectomy directly influences the internal volume of the resulting stomach. A smaller bougie produces a narrower, more restrictive sleeve with a lower capacity, whilst a larger bougie results in a wider sleeve that can accommodate greater food volumes. This relationship has important implications for both short- and long-term weight loss.

Some published meta-analyses and systematic reviews (for example, studies in the journal Obesity Surgery) have suggested that smaller bougie sizes (32–36 Fr) may be associated with greater excess weight loss in the short to medium term, largely due to enhanced restriction. However, any benefit in weight loss appears modest and may attenuate at two years or beyond; the evidence is not entirely consistent, and some studies have found no statistically significant difference in weight loss outcomes between bougie sizes when other technical variables are controlled.

Beyond weight loss, sleeve volume also influences:

• Gastro-oesophageal reflux disease (GORD): A tighter sleeve may increase intragastric pressure, potentially worsening or precipitating reflux symptoms. However, GORD risk after sleeve gastrectomy is multifactorial — contributing factors include the presence of a hiatus hernia, antral size, and staple line configuration. Preoperative assessment for hiatus hernia is important, as concurrent repair may reduce postoperative reflux risk.

• Nutritional adequacy: A more restrictive sleeve may make it harder for patients to meet protein and micronutrient targets, particularly in the early postoperative period. BOMSS guidance recommends lifelong nutritional supplementation and structured dietetic follow-up after bariatric surgery.

• Sleeve dilation over time: There is some evidence that sleeves can dilate gradually over years, which may reduce restriction; however, the degree to which initial bougie size influences long-term dilation remains uncertain and is subject to confounding by dietary behaviour and other factors.

It is important to recognise that bougie size is only one factor among many — including dietary adherence, physical activity, psychological support, and hormonal changes — that collectively determine a patient's weight loss journey following surgery.

UK Surgical Practice and NICE Guidance on Sleeve Gastrectomy

NICE CG189 recommends bariatric surgery for adults with a BMI ≥40, or ≥35 with a significant comorbidity; NICE does not specify bougie size, which remains a matter of surgical technique and clinical judgement.

In the United Kingdom, bariatric surgery — including sleeve gastrectomy — is commissioned and regulated within a framework informed by NICE guidance. The principal UK eligibility guidance is NICE CG189 (Obesity: identification, assessment and management), supported by NICE Quality Standard QS127. NICE also published interventional procedures guidance on laparoscopic sleeve gastrectomy (IPG432), which addresses the safety and efficacy of the procedure.

Under NICE CG189, bariatric surgery is recommended for consideration in adults with:

• A BMI of 40 kg/m² or above, or

• A BMI of 35–39.9 kg/m² with a significant obesity-related comorbidity (such as type 2 diabetes, hypertension, or obstructive sleep apnoea) that could be improved with weight loss.

• Surgery may also be considered for adults with a BMI of 30–34.9 kg/m² with recent-onset type 2 diabetes, where this is assessed as the most appropriate treatment option.

• Lower BMI thresholds apply for people of Asian family origin, for whom the health risks associated with obesity occur at a lower BMI; clinicians should refer to NICE CG189 for specific thresholds.

In all cases, NICE recommends that non-surgical interventions should have been tried and not achieved or maintained clinically significant weight loss before surgery is considered.

UK care pathway: In England, patients are typically required to complete a Tier 3 specialist weight management programme (a structured, multidisciplinary community or hospital-based service) before being referred for Tier 4 bariatric surgery. This ensures that surgical candidates have engaged with dietary, physical activity, and behavioural support prior to any operative intervention.

NICE guidance does not specify a particular bougie size for sleeve gastrectomy, as this falls within the domain of surgical technique and clinical judgement. The British Obesity and Metabolic Surgery Society (BOMSS) provides quality standards and guidance for UK bariatric practice, including expectations around multidisciplinary care, audit, and follow-up.

The NHS England commissioning framework requires that bariatric centres participate in national audit through the National Bariatric Surgery Registry (NBSR), which collects data on surgical outcomes including complications and weight loss. This registry supports ongoing evaluation of technical practices at a population level.

Patients in the UK accessing sleeve gastrectomy through the NHS will typically undergo a comprehensive preoperative assessment process, including dietetic review, psychological evaluation, and medical optimisation, before any surgical decisions — including those relating to operative technique — are finalised. Further patient-facing information is available on the NHS website (nhs.uk) under 'Weight loss surgery'.

Risks and Complications Associated With Different Bougie Sizes

Complications including staple line leak (incidence approximately 1–3%), GORD, stricture, and nutritional deficiencies are multifactorial; no single bougie size has been definitively linked to individual complications in isolation.

Bougie size is one of several technical factors that may influence the risk profile of sleeve gastrectomy, though it is important to note that no direct causal link has been definitively established between any specific bougie size and individual complications in isolation. Complications are multifactorial and influenced by patient characteristics, surgical experience, centre volume, and a range of intraoperative technical decisions.

The following associations have been reported in the surgical literature:

• Staple line leak: This is one of the most serious complications of sleeve gastrectomy. UK and international audit data suggest an approximate incidence of 1–3%, though rates vary by centre volume and case complexity. Leak risk is multifactorial — relevant factors include staple line ischaemia, tension, and technical factors — and is not determined by bougie size alone. Some evidence suggests that a very tight sleeve (smaller bougie) may increase intraluminal pressure, potentially contributing to leak risk, though this remains debated in the literature.

• Gastro-oesophageal reflux disease (GORD): Smaller bougie sizes and the resulting higher-pressure sleeve environment have been associated with new-onset or worsening GORD in some studies. Patients with pre-existing reflux or a hiatus hernia require careful preoperative counselling, as sleeve gastrectomy may exacerbate symptoms. Concurrent hiatal hernia repair at the time of sleeve gastrectomy may reduce this risk.

• Stricture or stenosis: A narrow sleeve, particularly if there is any twisting or angulation of the staple line, can result in functional obstruction. This may present as persistent vomiting, dysphagia, or intolerance of solid foods.

• Nutritional deficiencies: A highly restrictive sleeve may impair adequate oral intake, increasing the risk of protein malnutrition and micronutrient deficiencies, particularly in the early postoperative months. BOMSS guidance recommends lifelong vitamin and mineral supplementation after bariatric surgery.

When to seek urgent help: If you experience any of the following after surgery, contact your bariatric team immediately, call NHS 111, or attend your nearest Emergency Department (call 999 if symptoms are severe or rapidly worsening):

• Severe or worsening abdominal or chest pain

• Persistent vomiting or inability to keep fluids down

• Fever or signs of infection

• Difficulty swallowing or breathing

• Rapid heart rate or feeling faint

If you experience a problem with a medical device used during your procedure, this can be reported to the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk.

Choosing the Right Bougie Size: What to Discuss With Your Surgeon

Bougie size selection is a clinical decision made by your surgeon; patients should ask about the rationale for the chosen size, centre complication rates, NBSR audit participation, and how individual anatomy or reflux risk may influence the approach.

The selection of bougie size is ultimately a clinical decision made by your bariatric surgeon, informed by their training, experience, the evidence base, and your individual anatomy and health profile. However, as an informed patient, there are several meaningful questions you can raise during your preoperative consultations.

Questions worth discussing with your surgeon include:

• What bougie size do you routinely use, and what is the rationale for this choice?

• How does your centre's approach align with current evidence and BOMSS quality standards, and how are your outcomes audited through the NBSR?

• How will my individual anatomy or comorbidities (such as pre-existing reflux or a hiatus hernia) influence your technical approach?

• What sleeve volume are you aiming to achieve, and how does this relate to expected weight loss?

• What are your centre's complication rates, and how do these compare with national benchmarks?

It is also worth discussing your personal priorities. For example, if you have pre-existing GORD or are at higher risk of reflux, your surgeon may consider a slightly larger bougie, concurrent hiatal hernia repair, or may recommend an alternative procedure such as Roux-en-Y gastric bypass, which is generally associated with improvement rather than worsening of reflux symptoms.

Regardless of the technical parameters chosen on the day of surgery, all patients undergoing bariatric procedures should expect lifelong follow-up, including:

• Structured dietetic support and monitoring of nutritional intake

• Lifelong vitamin and mineral supplementation, as recommended by BOMSS guidance

• Regular blood tests to monitor for nutritional deficiencies

• Ongoing psychological and behavioural support as needed

Remember that sleeve gastrectomy is one component of a lifelong commitment to dietary change, physical activity, and regular follow-up. The bougie size contributes to the physical restriction the sleeve provides, but sustainable weight loss depends equally on behavioural, nutritional, and psychological factors. Engaging fully with your multidisciplinary bariatric team — including dietitians, psychologists, and specialist nurses — will support the best possible long-term outcome.

Frequently Asked Questions